LGND Jun 2024 85.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

5.50

-1.50

(-21.43%)

At close: 11:33AM EDT

Loading interactive chart…

Zacks
Roche (RHHBY), Ascidian Team Up for RNA Exon Editing Therapeutics
Roche (RHHBY) gets exclusive, target-specific rights to Ascidian's RNA exon editing technology for undisclosed neurological targets for an initial payment of $42 million.
Zacks
Terns (TERN) Gains 13.6% YTD: Will the Momentum Continue?
Terns Pharmaceuticals, Inc. (TERN) outperforms the industry year to date on encouraging pipeline progress of its oncology candidate.
Simply Wall St.
The past three years for Ligand Pharmaceuticals (NASDAQ:LGND) investors has not been profitable
Ligand Pharmaceuticals Incorporated ( NASDAQ:LGND ) shareholders should be happy to see the share price up 10% in the...